HempFusion’s Successful Debut on the TSX
At Cannin, we take great pleasure every time our stock recommendations create wealth for investors. Cannin recommended that our members consider buying shares in HempFusion’s stock ahead of its January 6th IPO and boy did this stock deliver. HempFusion’s successful debut on the TSX had this hemp stock soaring over 65% to end day one at $1.65. Since then, the stock has gone up a further 26% and closed trading at $2.08 on January 20. Remember, Cannin.com has over two years of successful stock picks. In fact, 78% of our picks prove to be true within 30 days or less.
[stock_market_widget type=”leaderboard” symbol=”CBD-U.TO” template=”basic” color=”default”]
HempFusion Capitalizes on Growing Global CBD Demand
Cannabidiol or CBD is currently among the fastest-growing consumer health products as there is continued more buyer awareness and acceptance of CBD today. As countries around the world continue to legalize cannabis, the CBD market is poised for sustained growth. In fact, according to Research and Markets, “The global CBD oil and CBD consumer health market size is expected to reach USD 123.2 billion by 2027, expanding at a CAGR of 25.6% over the forecast period.”
CBD market intelligence firm, Brightfield says that the US CBD market is set to hit $16.8 billion by 2025. In 2019, CBD sales were $4.1 billion. Cannabis’ relaxing properties have seen a massive increase in demand after the COVID-19 pandemic. Investors want to buy into companies that have a good hold on this market.
HempFusion is well positioned to dominate the CBD space. The company makes CBD-based capsules, liquids, and balms. It is based in Denver, Colorado, and will look at a possible listing on the NYSE (New York Stock Exchange). SWith Joe Biden assuming office as the 46th US President, market analysts say that the government will look to decriminalize or even legalize cannabis.
HempFusion’s FDA Compliance
HempFusion’s biggest advantage over its peers like Charlotte’s Web and CV Services is the fact that it has FDA-listed OTC products (Food and Drug Administration). Its topical products provide relief to specific conditions like pain, acne, eczema, and more. This is a minor coup in itself. FDA approval is notoriously difficult to obtain and companies take up to 24 months before receiving approval. HempFusion has jumped through all the regulatory hoops and can now focus on the road ahead.
HempFusion has started conducting studies for liver toxicology and has completed the NOAEL Safety Review for all topicals with about 30 new products under development. All of these new products will increase the company’s customer base. FDA approval means retailers are going to be confident of stocking these OTC topical products.
HempFusion has a network of around 4,000 retailers across all 50 US states and certain international markets through which it distributes close to 50 stock keeping units (SKUs). The company has expanded its distribution network beyond small scale retail and e-commerce platforms into doctor and practitioner lines and networks. It has also made inroads into convenience stores and big-box retailers.
HempFusion’s International Expansion
HempFusion hasn’t stopped with regulation at just North American shores. The company is entering Europe through an exclusive distribution play with a European distributor with an extensive retail store network. The company is entering Europe via Ireland and has the full acknowledgment of the Food Safety Authority of Ireland (FSAI). HempFusion’s recent press release states, “The expansion includes fully European Union compliant labeling, packaging and distribution for select HempFusion CBD & Probulin Probiotics products.”
HempFusion’s Probulin probiotics are growing fast in the US. This brand doesn’t contain CBD. SPINS syndicated data says that Probulin was one of the fastest-growing probiotics brands in the US in 2020. Probulin is a core of HempFusion’s CBD marketing strategy and it provides the company a gateway into countries where CBD is not yet legal. HempFusion’s products, like Probulin probiotics, can also be found on the Amazon Marketplace.
Currently, Probulin is being sold in the US, Mexico, South Korea, Ireland, and the United Arab Emirates (UAE). If these markets change their stance on CBD, HempFusion will already have the infrastructure that is needed to be an early mover on these markets.
With so much promise, you’ll definitely want to take Cannin’s ‘strong buy’ recommendation and consider investing in HempFusion stock.
HempFusion’s Successful Debut on the TSX
HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research, and HF Labs, to approximately 4,000 retailers across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 46 SKUs including tinctures, proprietary FDA Drug Listed Over-The-Counter (OTC) Topicals, Doctor/Practitioner Lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusion’s wholly-owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex™ and are available in-store or by visiting HempFusion online at www.hempfusion.com or www.probulin.com.
Jason Mitchell, N.D.
Chief Executive Officer and Director
Cannin Investment Group: Your Hemp Stocks Experts
Cannin.com is your trusted resource for hemp stocks. Our team of financial experts evaluates all emerging hemp stock investing opportunities. We aggregate hundreds of hours of market research to provide tips on the best hemp stocks for 2020.
Use Cannin as your resource for:
- Cannabis and hemp stocks & investing news
- Featured cannabis & hemp stocks analysis
- Comprehensive cannabis and hemp stock reports
Is it too late to invest in hemp stocks? No! This is the perfect time to invest.
Wall Street analysts expect the global cannabis industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in hemp stocks is now.
Are you looking to buy stock in hemp companies or marijuana companies in 2020? Interested in emerging penny hemp stocks? Interested in leveraging the power of algorithmic stock trades to profit from hemp stocks? Looking for the best Canadian cannabis stocks to invest in? We can help.
Predict price movements of hemp stocks several hours in advance with our proprietary algorithmic stock trading software.
- +25% Gains in 2020
- +49.8% Gains in 2019
- Backtested since 2012
At Cannin, we’re so confident you’ll love our algotrading hemp stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.
Profit from the best hemp stocks – we’ll show you how at cannin.com.
Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Best Hemp Stocks